Decision making – made easier
The latest presentations on the new ESC Guidelines, unveiled at ESC Congress, are now available on ESC 365. The best part? They're absolutely free for everyone to watch!
These guidelines will help you weigh the benefits and risks of diagnostic and therapeutic procedures. Your gateway to knowledge is wide open, so follow the path below and start exploring now. Want more? There are also two Hot Lines for you to discover.
ESC Clinical Practice Guidelines
|
|
Cardiovascular disease in patients with diabetes Get recommendations on CV risk stratification as well as the screening, diagnosis, and treatment of CVD in patients with diabetes. Access the scientific presentation from ESC Congress 2023. Watch the ESC TV summary.
|
|
|
Endocarditis Explore these new guidelines which should lead to improved outcomes for patients with infective endocarditis. They include a new diagnostic algorithm to help correctly classify patients. Access the scientific presentation from ESC Congress 2023. Watch the ESC TV summary.
|
|
|
Cardiomyopathies Discover the guidance on the diagnosis and management of patients with cardiomyopathies, according to the best available evidence. Access the scientific presentation from ESC Congress 2023. Watch the ESC TV summary.
|
|
|
Acute coronary syndromes For the first time, get recommendations for the management of patients across the entire spectrum of ACS in one document. Particular focus is given in these guidelines to the importance of anti-thrombotic therapy, invasive assessment and revascularisation. Access the scientific presentation from ESC Congress 2023. Watch the ESC TV summary.
|
|
|
Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Delve into the changes in recommendations for the treatment of HF due to new evidence from several randomised controlled trials. Updates include guidance for the treatment of HFmrEF, HFpEF, comorbidities and acute HF. Access the scientific presentation from ESC Congress 2023. Watch the ESC TV summary. |
Hot Lines
The results of major clinical studies are shared at ESC Congress in the Hot Lines sessions, like the two below. As these can improve patient outcomes and impact clinical practice they are always very popular sessions.
|
|
Hot Line 1: NOAH-AFNET 6 Find out about the investigator-driven, double-blind NOAH-AFNET 6 trial, the first to investigate the efficacy and safety of oral anticoagulation in patients with AHRE, but without ECG-documented AF.
|
 |
Hot Line 2: HEART-FID Explore the findings of the HEART-FID trial on the safety of IV ferric carboxymaltose (FCM) in iron-deficient patients with heart failure and reduced or mildly reduced ejection fraction. |
ESC Professional Members get year-round access to these session recordings, and much more! Membership gives you many additional benefits - it’s quick and easy to do and opens up a world of scientific and career development resources, all year long.
Find out about ESC Professional Membership and join today.
Your ESC Team
Our Diversity Is Our Strength